Literature DB >> 18180906

Rats surviving injurious mechanical ventilation show reversible pulmonary, vascular and inflammatory changes.

Nicolás Nin1, José A Lorente, Marta de Paula, Mariam El Assar, Susana Vallejo, Oscar Peñuelas, Pilar Fernández-Segoviano, Antonio Ferruelo, Alberto Sánchez-Ferrer, Andrés Esteban.   

Abstract

OBJECTIVE: To describe the time course of the changes in pulmonary and vascular function, and systemic inflammation induced by injurious mechanical ventilation.
DESIGN: Experimental study in an animal model of ventilator-induced lung injury.
SETTING: Animal research laboratory.
METHODS: Anesthetized male adult Sprague-Dawley rats were ventilated with VT 9 ml/kg and PEEP 5 cmH2O, or VT 35 ml/kg and zero PEEP for 1 h, and were killed. Other rats received ventilation for 1 h with high VT, to observe survival (n=36), or to be monitored and killed at different points in time (24, 72 and 168 h; n=7 in each group). Blood samples for measuring biochemical parameters were obtained. Post-mortem, a bronchoalveolar lavage (BAL) was performed, the aorta and pulmonary microvessels were isolated to examine ex-vivo vascular responses and pulmonary slices were examined (light microscopy). MEASUREMENTS AND
RESULTS: Mortality in rats ventilated with high VT was 19 of 36 (54%). Mechanical ventilation was associated with hypotension, hypoxaemia and membrane hyaline formation. AST, ALT, IL-6, MIP-2 serum and BAL fluid concentrations, as well as VEGF BAL fluid concentration, were increased in rats ventilated with high VT. Lung injury score was elevated. Aortic vascular responses to acetylcholine and norepinephrine, and microvascular responses to acetylcholine, were impaired. These changes resolved by 24-72 h.
CONCLUSIONS: Injurious ventilation is associated with respiratory and vascular dysfunction, accompanied by pulmonary and systemic inflammation. The survival rate was about 50%. In survivors, most induced changes completely normalized by 24-72 h after the insult.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180906     DOI: 10.1007/s00134-007-0959-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  Stretch-induced mitogen-activated protein kinase activation and interleukin-8 production in type II alveolar cells.

Authors:  D Quinn; A Tager; P M Joseph; J V Bonventre; T Force; C A Hales
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

2.  Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome.

Authors:  V M Ranieri; F Giunta; P M Suter; A S Slutsky
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

3.  Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome.

Authors:  D R Thickett; L Armstrong; S J Christie; A B Millar
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

4.  Lethal systemic capillary leak syndrome associated with severe ventilator-induced lung injury: an experimental study.

Authors:  Srinivas Mandava; Theodor Kolobow; Giovanni Vitale; Giuseppe Foti; Michele Aprigliano; Michael Jones; Eckhard Müller
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

5.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 6.  Ventilator-induced lung injury: lessons from experimental studies.

Authors:  D Dreyfuss; G Saumon
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 30.528

7.  Ventilation-induced lung injury is associated with an increase in gut permeability.

Authors:  Benoit P Guery; David A Welsh; Nathalie B Viget; Laurent Robriquet; Patrice Fialdes; Carol M Mason; Gilles Beaucaire; Greg J Bagby; Remi Neviere
Journal:  Shock       Date:  2003-06       Impact factor: 3.454

8.  Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats.

Authors:  D Dreyfuss; G Basset; P Soler; G Saumon
Journal:  Am Rev Respir Dis       Date:  1985-10

9.  Severe acute respiratory failure managed with continuous positive airway pressure and partial extracorporeal carbon dioxide removal by an artificial membrane lung. A controlled, randomized animal study.

Authors:  M Borelli; T Kolobow; R Spatola; P Prato; K Tsuno
Journal:  Am Rev Respir Dis       Date:  1988-12

10.  A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.

Authors:  Stephen M Eppler; Daniel L Combs; Timothy D Henry; John J Lopez; Stephen G Ellis; Joo-Hee Yi; Brian H Annex; Edward R McCluskey; Thomas F Zioncheck
Journal:  Clin Pharmacol Ther       Date:  2002-07       Impact factor: 6.875

View more
  15 in total

1.  Ventilator-induced lung injury: another sign of aging?

Authors:  Joan R Badia; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

2.  Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway.

Authors:  Rosanna Vaschetto; Jan W Kuiper; René J P Musters; Etto C Eringa; Francesco Della Corte; Kanneganti Murthy; A B Johan Groeneveld; Frans B Plötz
Journal:  Crit Care       Date:  2010-03-26       Impact factor: 9.097

3.  Murine mechanical ventilation stimulates alveolar epithelial cell proliferation.

Authors:  Patricia Rose Chess; Randi Potter Benson; William M Maniscalco; Terry W Wright; Michael A O'Reilly; Carl J Johnston
Journal:  Exp Lung Res       Date:  2010-08       Impact factor: 2.459

4.  Effects of trauma, hemorrhagic shock, and chronic stress on lung vascular endothelial growth factor.

Authors:  Tyler J Loftus; Andrew J Thomson; Kolenkode B Kannan; Ines G Alamo; Harry N Ramos; Elizabeth E Whitley; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2016-11-02       Impact factor: 2.192

5.  TLR4 is required for macrophage efferocytosis during resolution of ventilator-induced lung injury.

Authors:  Kai Su; Lulong Bo; Chunling Jiang; Xiaoming Deng; You-Yang Zhao; Richard D Minshall; Guochang Hu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-08-18       Impact factor: 6.011

6.  Role of free radicals in vascular dysfunction induced by high tidal volume ventilation.

Authors:  Leticia Martínez-Caro; José A Lorente; Judith Marín-Corral; Carolina Sánchez-Rodríguez; Alberto Sánchez-Ferrer; Nicolás Nin; Antonio Ferruelo; Marta de Paula; Pilar Fernández-Segoviano; Esther Barreiro; Andrés Esteban
Journal:  Intensive Care Med       Date:  2009-04-10       Impact factor: 17.440

Review 7.  Repair after acute lung injury: molecular mechanisms and therapeutic opportunities.

Authors:  Adrián González-López; Guillermo M Albaiceta
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

8.  Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury.

Authors:  Maria A Hegeman; Marije P Hennus; Matijs van Meurs; Pieter M Cobelens; Annemieke Kavelaars; Nicolaas J Jansen; Marcus J Schultz; Adrianus J van Vught; Grietje Molema; Cobi J Heijnen
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

9.  Dexamethasone attenuates VEGF expression and inflammation but not barrier dysfunction in a murine model of ventilator-induced lung injury.

Authors:  Maria A Hegeman; Marije P Hennus; Pieter M Cobelens; Annemieke Kavelaars; Nicolaas J G Jansen; Marcus J Schultz; Adrianus J van Vught; Cobi J Heijnen
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Low tidal volume protects pulmonary vasomotor function from "second-hit" injury in acute lung injury rats.

Authors:  Chun Pan; Jianqiang Wang; Wei Liu; Ling Liu; Liang Jing; Yi Yang; Haibo Qiu
Journal:  Respir Res       Date:  2012-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.